Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 2;12(6):1647.
doi: 10.3390/nu12061647.

A Scoping Review of Interactions between Omega-3 Long-Chain Polyunsaturated Fatty Acids and Genetic Variation in Relation to Cancer Risk

Affiliations

A Scoping Review of Interactions between Omega-3 Long-Chain Polyunsaturated Fatty Acids and Genetic Variation in Relation to Cancer Risk

Karin Yurko-Mauro et al. Nutrients. .

Abstract

This scoping review examines the interaction of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) and genetic variants of various types of cancers. A comprehensive search was performed to identify controlled and observational studies conducted through August 2017. Eighteen unique studies were included: breast cancer (n = 2), gastric cancer (n = 1), exocrine pancreatic cancer (n = 1), chronic lymphocytic leukemia (n = 1), prostate cancer (n = 7) and colorectal cancer (n = 6). An additional 13 studies that focused on fish intake or at-risk populations were summarized to increase readers' understanding of the topic based on this review, DHA and EPA interact with certain genetic variants to decrease breast, colorectal and prostate cancer risk, although data was limited and identified polymorphisms were heterogeneous. The evidence to date demonstrates that omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) may decrease cancer risk by affecting genetic variants of inflammatory pathways, oxidative stress and tumor apoptosis. Collectively, data supports the notion that once a genetic variant is identified, the benefits of a targeted, personalized therapeutic regimen that includes DHA and/or EPA should be considered.

Keywords: cancer; docosahexaenoic acid; eicosapentaenoic acid; genes; genetic variation; genotype; omega-3; polyunsaturated fatty acids; scoping review.

PubMed Disclaimer

Conflict of interest statement

K.Y.M. was an employee of DSM Nutritional Products. M.V.E. and L.T. are consultants to DSM Nutritional Products and received monetary compensation from DSM for work related to this manuscript.

Figures

Figure 1
Figure 1
PubMed search string.
Figure 2
Figure 2
Flow diagram of the search and screen process used in study selection.
Figure 3
Figure 3
Number of studies by study design type split by cancer type.

Similar articles

Cited by

References

    1. Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Piñeros M., Znaor A., Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer. 2019;144:1941–1953. doi: 10.1002/ijc.31937. - DOI - PubMed
    1. Heron M. Deaths: Leading Causes for 2017. National Center for Health Statistics; Hyattsville, MD, USA: 2019. - PubMed
    1. Triff K., Kim E., Chapkin R.S. Chemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiber. Curr. Pharm. Rep. 2015;1:11–20. doi: 10.1007/s40495-014-0005-7. - DOI - PMC - PubMed
    1. Calder P.C. Very long-chain n-3 fatty acids and human health: Fact, fiction and the future. Proc. Nutr. Soc. 2018;77:52–72. doi: 10.1017/S0029665117003950. - DOI - PubMed
    1. Gao M., Sun K., Guo M., Gao H., Liu K., Yang C., Li S., Liu N. Fish consumption and n-3 polyunsaturated fatty acids, and risk of hepatocellular carcinoma: Systematic review and meta-analysis. Cancer Causes Control. 2015;26:367–376. doi: 10.1007/s10552-014-0512-1. - DOI - PubMed

Publication types

Substances